Cancer 50 Gene Panel NGS Test sale cost 6000 AED
Oncomine Acute Myeloid Leukemia AML Panel Test sale cost 8260 AED Oncomine Acute Myeloid Leukemia AML Panel Test Cost 9,180 د.إ Original price was: 9,180 د.إ.8,260 د.إCurrent price is: 8,260 د.إ.
Cancer Targeted Gene Panel Lung with PDL-1 DAKO Test sale cost 5400 AED Cancer Targeted Gene Panel Lung with PDL-1 DAKO Test Cost 7,200 د.إ Original price was: 7,200 د.إ.5,400 د.إCurrent price is: 5,400 د.إ.
Sale!

Cancer 50 Gene Panel NGS Test Cost

Original price was: 8,000 د.إ.Current price is: 6,000 د.إ.

-25%

The “Cancer 50 Gene Panel NGS (Next-Generation Sequencing) Test” is a comprehensive diagnostic tool offered by DNA Labs UAE, designed to detect mutations in 50 genes that are commonly associated with a variety of cancers. This cutting-edge test utilizes the latest in NGS technology to provide a detailed genetic profile, helping healthcare professionals to identify genetic predispositions to cancer, guide treatment decisions, and determine a patient’s risk of developing certain types of cancer. By analyzing a small sample of the patient’s DNA, this test can uncover specific genetic abnormalities that may influence the behavior of cancer, including how aggressively it grows or how it responds to certain treatments. Priced at 6000 AED, this test represents a significant investment in personal health, offering invaluable insights for individuals at risk of cancer or those seeking personalized cancer treatment strategies.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CANCER 50 GENE PANEL NGS Test

Test Name: CANCER 50 GENE PANEL NGS Test

Components: ABL1, EGFR, GNAS, KRAS, PTPN11, AKT1, ERBB2, GNAQ, MET, RB1, ALK, ERBB4, HNF1A, MLH1, RET, APC, EZH2, HRAS, MPL, SMAD4, ATM, FBXW7, IDH1, NOTCH1, SMARCB1, BRAF, FGFR1, JAK2, NPM1, SMO, CDH1, FGFR2, JAK3, NRAS, SRC, CDKN2A, FGFR3, IDH2, PDGFRA, STK11, CSF1R, FLT3, KDR, PIK3CA, TP53, CTNNB1, GNA11, KIT, PTEN, VHL

Price: 6000.0 AED

Sample Condition:

  • For Leukemias: Submit 3 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE.
  • For Solid tumors: Submit formalin fixed paraffin embedded tissue block. Ship at room temperature. Block should have at least 10% tumor tissue.

Report Delivery: Sample Mon by 11 am; Report 10 Working days

Method: Next Generation Sequencing

Test type: Cancer

Doctor: Oncologist

Test Department: MOLECULAR DIAGNOSTICS

Pre Test Information: Duly filled NGS Test Requisition Form is mandatory.

Test Details:

The Cancer 50 Gene Panel NGS Test is a genetic test that analyzes a panel of 50 genes associated with various types of cancer. The test uses Next-Generation Sequencing (NGS) technology to identify mutations and genetic alterations in these genes, which can help healthcare professionals to diagnose and treat cancer more effectively.

The Cancer 50 Gene Panel NGS Test is typically used for patients with a family history of cancer or those who have already been diagnosed with cancer. The test can help identify genetic mutations that may increase the risk of developing cancer, as well as mutations that may affect the effectiveness of certain cancer treatments.

Some of the genes included in the Cancer 50 Gene Panel NGS Test include BRCA1 and BRCA2 (associated with breast and ovarian cancer), TP53 (associated with multiple types of cancer), and KRAS (associated with lung, pancreatic, and colorectal cancer).

Overall, the Cancer 50 Gene Panel NGS Test can provide valuable information for healthcare professionals to make more informed decisions about cancer diagnosis and treatment, potentially leading to improved outcomes for patients.

Test Name CANCER 50 GENE PANEL NGS Test
Components ABL1, EGFR, GNAS, KRAS, PTPN11, AKT1, ERBB2, GNAQ, MET, RB1, ALK, ERBB4, HNF1A, MLH1, RET, APC, EZH2, HRAS, MPL, SMAD4, ATM, FBXW7, IDH1, NOTCH1, SMARCB1, BRAF, FGFR1, JAK2, NPM1, SMO, CDH1, FGFR2, JAK3, NRAS, SRC, CDKN2A, FGFR3, IDH2, PDGFRA, STK11, CSF1R, FLT3, KDR, PIK3CA, TP53, CTNNB1, GNA11, KIT, PTEN, VHL
Price 6000.0 AED
Sample Condition For Leukemias: Submit 3 mL (2 mL min.) whole blood in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE.\nFor Solid tumors: Submit formalin fixed paraffin embedded tissue block. Ship at room temperature. Block should have at least 10% tumor tissue. \nDuly filled NGS Test Requisition Formis mandatory.
Report Delivery Sample Mon by 11 am; Report 10 Working days
Method Next Generation Sequencing
Test type Cancer
Doctor Oncologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information Duly filled NGS Test Requisition Formis mandatory.
Test Details

The Cancer 50 Gene Panel NGS Test is a genetic test that analyzes a panel of 50 genes associated with various types of cancer. The test uses Next-Generation Sequencing (NGS) technology to identify mutations and genetic alterations in these genes, which can help healthcare professionals to diagnose and treat cancer more effectively.

The Cancer 50 Gene Panel NGS Test is typically used for patients with a family history of cancer or those who have already been diagnosed with cancer. The test can help identify genetic mutations that may increase the risk of developing cancer, as well as mutations that may affect the effectiveness of certain cancer treatments.

Some of the genes included in the Cancer 50 Gene Panel NGS Test include BRCA1 and BRCA2 (associated with breast and ovarian cancer), TP53 (associated with multiple types of cancer), and KRAS (associated with lung, pancreatic, and colorectal cancer).

Overall, the Cancer 50 Gene Panel NGS Test can provide valuable information for healthcare professionals to make more informed decisions about cancer diagnosis and treatment, potentially leading to improved outcomes for patients.

SKU: TEST-780 Category:

Related products